CAPITOL CITY GROUP, LTD.

Lobbying for ARDELYX, INC. · discovering, developing and commercializing medicine

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Massachusetts · House · Senate · $50,000.00 income · posted Oct 16, 2025

Lobbying activity 1

Health Issues

Assist client with matters re: kidney dialysis drugs and renal drugs; assist client with medicare/CMS issues; assist re: issues on ESRD related drugs and medicare ESRD prospective payment system.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.